Related Experiment Video
Updated: Aug 27, 2025

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome
Daniel A Bonsor1, Patrick Alexander1, Kelly Snead1
1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Abstract:
SHOC2 acts as a strong synthetic lethal interactor with MEK inhibitors in multiple KRAS cancer cell lines. SHOC2 forms a heterotrimeric complex with MRAS and PP1C that is essential for regulating RAF and MAPK-pathway activation by dephosphorylating a specific phosphoserine on RAF kinases. Here we present the high-resolution crystal structure of the SHOC2-MRAS-PP1C (SMP) complex and apo-SHOC2. Our structures reveal that SHOC2, MRAS, and PP1C form a stable ternary complex in which all three proteins synergistically interact with each other. Our results show that dephosphorylation of RAF substrates by PP1C is enhanced upon interacting with SHOC2 and MRAS. The SMP complex forms only when MRAS is in an active state and is dependent on SHOC2 functioning as a scaffolding protein in the complex by bringing PP1C and MRAS together. Our results provide structural insights into the role of the SMP complex in RAF activation and how mutations found in Noonan syndrome enhance complex formation, and reveal new avenues for therapeutic interventions.
Insights
SHOC2 protein forms a complex with MRAS and PP1C, enhancing RAF-MAPK pathway regulation. This structural insight into the SHOC2-MRAS-PP1C complex reveals therapeutic targets for KRAS cancers and Noonan syndrome.
Area of Science:
- Molecular Biology
- Structural Biology
- Oncology
Background:
- SHOC2 is a synthetic lethal interactor with MEK inhibitors in KRAS cancers.
- SHOC2 regulates RAF and MAPK pathway activation through a complex with MRAS and PP1C.
- This complex dephosphorylates RAF kinases, impacting cancer cell signaling.
Purpose of the Study:
- To determine the high-resolution crystal structure of the SHOC2-MRAS-PP1C (SMP) complex and apo-SHOC2.
- To elucidate the structural basis of SMP complex formation and its role in RAF activation.
- To identify potential therapeutic interventions based on structural insights.
Main Methods:
- X-ray crystallography to obtain high-resolution structures of the SMP complex and apo-SHOC2.
- Biochemical assays to assess the dephosphorylation activity of the complex.
- Structural analysis to understand protein-protein interactions within the complex.
Main Results:
- The crystal structure reveals a stable ternary complex formed by SHOC2, MRAS, and PP1C with synergistic interactions.
- Dephosphorylation of RAF substrates by PP1C is significantly enhanced within the SMP complex.
- SMP complex formation is dependent on the active state of MRAS and SHOC2's scaffolding function.
Conclusions:
- The SMP complex plays a crucial role in RAF activation, with SHOC2 acting as a scaffold.
- Structural insights explain how Noonan syndrome mutations enhance SMP complex formation.
- The study provides a foundation for developing novel therapeutic strategies targeting the SMP complex in cancer and genetic disorders.
Related Concept Videos
MAPK Signaling Cascades
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
cAMP-dependent Protein Kinase Pathways
ATP Synthase: Structure
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

